ischemic cardiomyopathy

dynaCERT Inc.
Latest Comments

Hemostemix adds depth and strength to its scientific bench on the road to commercialization

Since we last covered Hemostemix where they released the promising results of their retrospective study of heart disease and the […]

Thomas Smeenk of Hemostemix talks about market reaction to successful litigation settlement

In this InvestorIntel interview with host Stephen Lautens, Hemostemix Inc.’s (TSXV: HEM | OTCQB: HMTXF) Co-Founder, President and CEO Thomas […]

Hemostemix’s stem cell therapy pursues ‘Your Fountain of Youth’

What’s a company worth to investors that could improve numerous medical conditions related to ischemia (lack of blood flow) and […]

Built on arguably one of the greatest medical breakthroughs of our time, Hemostemix has ‘your fountain of youth’…

Stem cell therapy is potentially one of the greatest medical breakthroughs of our time. It is truly amazing that we […]

Revolutionizing the way we treat lack of blood flow diseases by using stem cell therapy

Every year modern medicine makes new breakthroughs that continue to amaze. Today’s company has a breakthrough ‘stem cell therapy,’ designed […]